当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:133.53亿  总市值:182.81亿
流通股本:12.22亿   总股本:16.73亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.63亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益434498.15万元,未分配利润175442.43万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产510062.42万元,负债75564.27万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,962,590,112.691,292,187,881.95628,754,570.482,536,042,781.68
营业总成本1,345,964,715.95885,306,876.29394,534,887.631,780,935,163.99
其他经营收益
营业利润649,500,746.76432,330,760.51247,966,620.6806,396,813.46
利润总额648,684,249.94432,081,021.92247,862,906.26803,016,702.92
净利润562,621,438.07374,553,615.38213,314,968.37715,837,906.16
每股收益
其他综合收益-78,746,995.87-71,008,287.24-44,881,085.5-
综合收益总额483,874,442.2303,545,328.14168,433,882.87715,837,906.16
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,293,623,522.182,080,675,526.92,091,782,205.872,275,095,785.01
非流动资产:
非流动资产合计2,807,000,688.382,842,287,396.643,012,443,453.752,860,254,070.71
资产总计5,100,624,210.564,922,962,923.545,104,225,659.625,135,349,855.72
流动负债:
流动负债合计606,627,204.9619,410,400.7681,080,762.88667,585,431.63
非流动负债:
非流动负债合计149,015,505.62159,831,213.97162,385,516.67167,826,723.08
负债合计755,642,710.52779,241,614.67843,466,279.55835,412,154.71
所有者权益(或股东权益):
归属于母公司股东权益合计4,168,905,179.473,970,430,014.834,085,098,104.474,124,312,564.42
股东权益合计4,344,981,500.044,143,721,308.874,260,759,380.074,299,937,701.01
负债和股东权益合计5,100,624,210.564,922,962,923.545,104,225,659.625,135,349,855.72
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,963,442,909.041,278,724,469.39593,182,584.392,505,216,350.95
经营活动现金流出小计1,407,604,611.42962,299,635.08397,953,607.491,819,844,403.86
经营活动产生的现金流量净额555,838,297.62316,424,834.31195,228,976.9685,371,947.09
投资活动产生的现金流量:
投资活动现金流入小计1,015,462,784.32982,110,968.71984,226,816.561,262,223,715.45
投资活动现金流出小计1,226,809,235.8801,658,281.841,008,274,689.411,432,471,328.52
投资活动产生的现金流量净额-211,346,451.48180,452,686.87-24,047,872.85-170,247,613.07
筹资活动产生的现金流量:
筹资活动现金流入小计33,991,248.2818,313,750-5,000,000
筹资活动现金流出小计486,888,523.67483,420,902.91206,540,716.57480,379,750.73
筹资活动产生的现金流量净额-452,897,275.39-465,107,152.91-206,540,716.57-475,379,750.73
汇率变动对现金及现金等价物的影响-3,069,341.75-2,908,775.77-2,470,049.3376,401.94
现金及现金等价物净增加额-111,474,77128,861,592.5-37,829,661.8539,820,985.23
期末现金及现金等价物余额187,130,163.97327,466,527.47260,775,273.12298,604,934.97
补充资料:
现金及现金等价物的净增加额-28,861,592.5-39,820,985.23
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券李雨涵,谭国超0.450.520.602025-08-27
华鑫证券吴景欢,胡博新0.480.560.652025-08-26
TOP↑